INFLUENCE OF VERAPAMIL ON THE INOTROPISM AND PHARMACOKINETICS OF DIGOXIN

被引：33

作者：

PEDERSEN, KE

THAYSSEN, P

KLITGAARD, NA

CHRISTIANSEN, BD

NIELSENKUDSK, F

机构：

[1] ODENSE UNIV HOSP,DEPT CLIN PHYSIOL,DK-5000 ODENSE C,DENMARK

[2] ODENSE UNIV HOSP,INTERNAL MED DEPT B,DK-5000 ODENSE C,DENMARK

[3] AARHUS UNIV,INST PHARMACOL,DK-8000 AARHUS C,DENMARK

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 25卷 / 02期

关键词：

D O I：

10.1007/BF00543791

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：199 / 206

页数：8

共 26 条

[1]

BALL WJ, 1979, FED PROC, V38, P1042

[2]

BELZ GG, 1981, LANCET, V1, P844

[3]

BELZ GG, 1982, EUR J CLIN PHARM, V22, P111

[4] DIGOXIN-QUINIDINE INTERACTION - CHANGES IN CANINE TISSUE CONCENTRATION FROM STEADY-STATE WITH QUINIDINE [J].

DOHERTY, JE ;

STRAUB, KD ;

MURPHY, ML ;

SOYZA, ND ;

BISSETT, JK ;

KANE, JJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (06) :1196-1200

[5] EFFECTS OF VERAPAMIL ON MYOCARDIAL PERFORMANCE IN CORONARY-DISEASE [J].

FERLINZ, J ;

EASTHOPE, JL ;

ARONOW, WS .

CIRCULATION, 1979, 59 (02) :313-319

[6] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].

FLECKENSTEIN, A .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166

[7]

FLECKENSTEIN A, 1972, ARZNEI-FORSCHUNG, V22, P22

[8]

FORRESTER W, 1974, CIRCULATION, V49, P517

[9]

GIBALDI M, 1975, PHARMACOKINETICS

[10]

GOLDMAN S, 1982, J PHARMACOL EXP THER, V222, P270

← 1 2 3 →